Evidence map›Paper›PMID 39969188›Full record

ArticleJournal of animal science2025

Improving genetic gain in postpartum cows: a modified ovarian superstimulation protocol for ovum pick-up-in vitro embryo production during the voluntary waiting period.

Jinbang Xiao, Manyuan Tian, Haojie Yuan, Hongyu Ren, Heqiang Li, Chengyun Xie, Cong Huang, Bingke Wang, Yongsheng Wang, Yaping Jin and 1 more

Abstract read
In one paragraph

Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jinbang XiaoCollege of Veterinary Medicine, Northwest A&F University, Shaanxi, China.ORCID 0000-0003-3921-0884
Manyuan TianCollege of Veterinary Medicine, Northwest A&F University, Shaanxi, China.
Haojie YuanCollege of Veterinary Medicine, Northwest A&F University, Shaanxi, China.
Hongyu RenCollege of Veterinary Medicine, Northwest A&F University, Shaanxi, China.
Heqiang LiCollege of Veterinary Medicine, Northwest A&F University, Shaanxi, China.ORCID 0009-0008-2875-7677
Chengyun XieCollege of Veterinary Medicine, Northwest A&F University, Shaanxi, China.
Cong HuangCollege of Veterinary Medicine, Northwest A&F University, Shaanxi, China.
Bingke WangCollege of Veterinary Medicine, Northwest A&F University, Shaanxi, China.
Yongsheng WangCollege of Veterinary Medicine, Northwest A&F University, Shaanxi, China.ORCID 0000-0002-8301-4031
Yaping JinCollege of Veterinary Medicine, Northwest A&F University, Shaanxi, China.
Pengfei LinCollege of Veterinary Medicine, Northwest A&F University, Shaanxi, China.ORCID 0000-0001-6815-4418

Funding

Key R&D Program of Ningxia, China 2024BBF01005Key R&D Project in Shaanxi Province 2024NC2-GJHX-13Key R&D Project in Shaanxi Province 2024NC-ZDCYL-03-03
6 · The paper itself

Abstract

Ovarian superstimulation-ovum pick-up (OPU) technology facilitates the rapid propagation of animals with excellent genetic potential, substantially shortening the interval between generations. Research regarding OPU implementation during the voluntary waiting period (VWP), a phase with potential for maximizing genetic gains in high-yield herds, is limited. We aimed to optimize the dosage and frequency of follicle-stimulating hormone (FSH) injections in postpartum cows to develop an ovarian superstimulation protocol during the VWP for OPU-IVF and assess its effect on milk production and reproductive performance. Cows with more than three parities and within the top 10% of 305-day milk yield were selected as OPU donors. Donor cows were eligible for ovarian superstimulation starting at 40 days in milk (DIM) if they had completed uterine involution and showed no signs of intrauterine infection. Two superstimulation protocols were compared: three injections of 167 IU FSH (FSH-3 group) and five injections of 100 IU FSH (FSH-5 group). Donor cows underwent OPU between DIM 40 and 75, followed by a 10 to 15-d waiting period before artificial insemination (AI). A total of 95 cows (113 OPU sessions) were assigned to the FSH-5 group and 116 cows (135 OPU sessions) to the FSH-3 group. Milk yield data during this period and subsequent reproduction records of these donor cows were compared with those of nondonor cows. The results showed that the FSH-3 group achieved better results, including more 2 to 6-mm follicles and 6 to 10-mm follicles, a greater total follicle count, and greater recovery of cumulus-oocyte complexes (P < 0.05). Additionally, the FSH-3 group produced more greater-grade oocytes, resulting in better production of blastocysts (P < 0.05). Although the application of superstimulation-OPU to donor cows during the VWP delayed the DIM of the first AI (P < 0.05), it significantly increased the pregnancy rate (P < 0.05) and did not affect the subsequent reproductive performance of the parity. Milk yield temporarily declined on the day of OPU, but it gradually recovered. In summary, the FSH-3 protocol generated an average of more than four embryos per cow during the VWP without compromising reproductive performance, including service and pregnancy rates. These results suggest that the FSH-3 protocol is an effective strategy for obtaining embryos from high-yield cows during the VWP, enhancing genetic gain and accelerating breeding programs with minimal effect on future fertility.

Indexed as

Fertilization in VitroFollicle Stimulating HormoneOocyte RetrievalOvulation InductionAnimalsCattleFemaleInsemination, ArtificialLactationPostpartum PeriodPregnancyFollicle Stimulating Hormonein vitro productionovarian superstimulationovum pick-upreproduction managementvoluntary waiting period

Identifiers

PMID39969188
PMCPMC12080540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.